Evidence map›Paper›PMID 28778189›Full record

ArticleBMC infectious diseases2017

The invasome of Salmonella Dublin as revealed by whole genome sequencing.

Manal Mohammed, Simon Le Hello, Pimlapas Leekitcharoenphon, Rene Hendriksen

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 66 citations in OpenAlex.

  1. Gut microbes · 2026
    Review
  2. Cross-species genomic analysis ofOne health (Amsterdam, Netherlands) · 2026
    Article
  3. Disseminated multidrug-resistant Salmonella enterica serovar Dublin infection associated with plasmid-borne CMY-2 gene in a patient with travel to a farm in Mexico.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Microbiology spectrum · 2026
    Article
  5. Article
  6. Article
  7. Prevalence and Antimicrobial Resistance Diversity ofAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review:Frontiers in veterinary science · 2023
    Review
  12. Clonal relation betweenFrontiers in veterinary science · 2023
    Article
  13. Article
  14. Article
  15. Whole-Genome Investigation ofMicroorganisms · 2022
    Article
  16. Epidemiology ofFrontiers in microbiology · 2022
    Article
  17. Safety of theFrontiers in veterinary science · 2022
    Article
  18. The European Union One Health 2020 Zoonoses Report.EFSA journal. European Food Safety Authority · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Manal MohammedDepartment of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. m.mohammed1@westminster.ac.uk.
Simon Le HelloUnité des Bactéries Pathogènes Entériques, Centre National de Référence des Salmonella, WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, Paris, France.
Pimlapas LeekitcharoenphonNational Food Institute, WHO Collaborating Center for Antimicrobial Resistance in Food borne Pathogens and Genomics and European Union Reference Laboratory for Antimicrobial Resistance, Technical University of Denmark, -2800, Kgs. Lyngby, DK, Denmark.
Rene HendriksenNational Food Institute, WHO Collaborating Center for Antimicrobial Resistance in Food borne Pathogens and Genomics and European Union Reference Laboratory for Antimicrobial Resistance, Technical University of Denmark, -2800, Kgs. Lyngby, DK, Denmark.
Technical University of Denmark · DKInstitut Pasteur · FRUniversity of Westminster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSalmonella enterica serovar Dublin is a zoonotic infection that can be transmitted from cattle to humans through consumption of contaminated milk and milk products. Outbreaks of human infections by S. Dublin have been reported in several countries including high-income countries. A high proportion of S. Dublin cases in humans are associated with invasive disease and systemic illness. The genetic basis of virulence in S. Dublin is not well characterized.

methodsWhole genome sequencing was applied to a set of clinical invasive and non-invasive S. Dublin isolates from different countries in order to characterize the putative genetic determinants involved in the virulence and invasiveness of S. Dublin in humans.

resultsWe identified several virulence factors that form the bacterial invasome and may contribute to increasing bacterial virulence and pathogenicity including mainly Gifsy-2 prophage, two different type 6 secretion systems (T6SSs) harbored by Salmonella pathogenicity islands; SPI-6 and SPI-19 respectively and virulence genes; ggt and PagN. Although Vi antigen and the virulence plasmid have been reported previously to contribute to the virulence of S. Dublin we did not detect them in all invasive isolates indicating that they are not the main virulence determinants in S. Dublin.

conclusionSeveral virulence factors within the genome of S. Dublin might contribute to the ability of S. Dublin to invade humans' blood but there were no genomic markers that differentiate invasive from non-invasive isolates suggesting that host immune response play a crucial role in the clinical outcome of S. Dublin infection.

Indexed as

Genome, BacterialAnimalsCattleGenomic IslandsHumansPlasmidsSalmonella entericaVirulenceVirulence FactorsVirulence FactorsGgtGifsy-2PagNSalmonella DublinSPI-19SPI-6T6SSVi antigenVirulence

Identifiers

PMID28778189
PMCPMC5544996
OpenAlexW2743399464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.